These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1982042)

  • 21. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
    Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
    Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
    Ramme D; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release.
    Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F
    Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone-induced analgesia: involvement of kappa-opiate receptors.
    Bianchi M; Panerai AE
    Pharmacol Biochem Behav; 1993 Sep; 46(1):145-8. PubMed ID: 8255904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative spinal analgesic action of dynorphin1-8, dynorphin1-13, and a kappa-receptor agonist U50,488.
    Jhamandas K; Sutak M; Lemaire S
    Can J Physiol Pharmacol; 1986 Mar; 64(3):263-8. PubMed ID: 2871911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
    Ueda H; Misawa H; Fukushima N; Takagi H
    Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
    Rochford J; Godin C; Henry JL
    Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
    Hong EK; Takemori AE
    J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperalgesia produced by intrathecal opioid antagonists depends on receptor selectivity and noxious stimulus.
    Pilcher CW; Browne JL
    NIDA Res Monogr; 1986; 75():469-72. PubMed ID: 2828994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro.
    Inenaga K; Nagatomo T; Nakao K; Yanaihara N; Yamashita H
    Neuroscience; 1994 Jan; 58(2):331-40. PubMed ID: 7908725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
    Stevens CW; Weinger MB; Yaksh TL
    Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of microiontophoretically-applied opioid peptides on Purkinje cells in the cat cerebellum.
    Taguchi K; Abe K; Chyuma T; Kato M; Shigenaga T; Kushida K; Chikuma T
    Acta Pharmacol Sin; 2000 Oct; 21(10):877-84. PubMed ID: 11501037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the analgesia inhibitory system by D-phenylalanine and proglumide.
    Takeshige C; Mera H; Hisamitsu T; Tanaka M; Hishida F
    Brain Res Bull; 1991 Mar; 26(3):385-91. PubMed ID: 2049604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors.
    Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F
    Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of opioid peptides on circular muscle of canine duodenum.
    Bauer AJ; Szurszewski JH
    J Physiol; 1991 Mar; 434():409-22. PubMed ID: 1673718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of spinal opioid analgesia by supraspinal administration of selective opioid antagonists.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 596(1-2):41-5. PubMed ID: 1361418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.